Assessing and training pitch perception and memory in cochlear implant users and those with congenital amusia
Pitch Perception and Memory: Deficits and Training
This study is testing a training program to see if it can help people with cochlear implants and those with congenital amusia improve their ability to hear and remember different pitches.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 960 (estimated) |
| Ages | 5 Years to 90 Years |
| Sex | All |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 1 site (Bron) |
| Trial ID | NCT03707691 on ClinicalTrials.gov |
What this trial studies
This study investigates pitch perception and memory in individuals with cochlear implants and those with congenital amusia, comparing their abilities to control listeners. It employs behavioral tests, EEG, and MEG recordings to identify pitch processing deficits and evaluates the effectiveness of a pitch training program. The research aims to enhance understanding of auditory cognition and improve auditory skills through targeted training interventions.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18-90 with cochlear implants or congenital amusia, as well as children aged 5 and older with parental consent.
Not a fit: Patients with significant neurological or psychiatric disorders, or those outside the specified age range, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve pitch perception and memory in patients with cochlear implants and congenital amusia, enhancing their auditory experiences.
How similar studies have performed: Other studies have shown promise in training auditory perception skills, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: For adult participants: * Aged between 18 and 90 * Absence of neurological and psychiatric disorders * No major cognitive deficit, ability to understand and apply study instructions * Motivation to participate efficiently in the study * Written informed consent to participant in the study * Affiliated to social security * Control participants and participants with congenital amusia for Experiment 5: MRI/MEG compatibility For underage participants: * Subject aged 5 years and over * Informed consent of parents or guardians for the participation of the child being studied * No neurological or psychiatric history * Without major cognitive impairment and ability to understand and apply setpoint. * Subject affiliated to a social security scheme * Motivation to participate effectively in the project Exclusion Criteria: For adult participants: * Age below 18 or above 90 * Pregnant or breast-feeding woman For underage participants: \- Pregnant or nursing minors
Where this trial is running
Bron
- Lyon Neuroscience Research Center — Bron, France (Recruiting)
Study contacts
- Principal investigator: Anne CACLIN — Hospices Civils de Lyon
- Study coordinator: Anne CACLIN
- Email: anne.caclin@inserm.fr
- Phone: 4 72 13 89 04
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.